PubMed Health⌕ Search

Biomedical subjects

M S Boyd

Publications and source records attributed to M S Boyd.

4 recordsLinked to original sources
PubMed1997

Charting patient satisfaction.

The importance of maintaining high levels of patient satisfaction has been well researched and thoroughly documented. Patient satisfaction can be measured, changed, controlled, and managed effectively to aid in improvement quality. Nevertheless, little research has been conducted to determine how patient satisfaction affects quality or how satisfaction strategies affect patients' perceptions. The authors of this study view patient satisfaction as a value-added component. They present a statistical process control-chart method that can help implement and evaluate a CQI strategy for improving patient satisfaction. The study illustrates how to measure patient satisfaction, create control charts, interpret the results, and develop administrative applications aimed at fulfilling a CQI strategy.

Data Collection↗
PubMed1977

Effect of surveillance on the number of hysterectomies in the province of Saskatchewan.

In 1972 the College of Physicians and Surgeons of Saskatchewan appointed a committee to study hysterectomies because the Saskatchewan Department of Health had data showing that the annual number of hysterectomies carried out in the province had increased by 72.1 per cent between 1964 and 1971, whereas the number of women over 15 years of age had increased by 7.6 per cent. The committee compiled a list of indications for hysterectomy. Any hysterectomy carried out for one of these reasons was classified as justified, and the remainder as unjustified. Five hospitals were reviewed in 1970 and a further two in 1973. In 1974, all seven hospitals were reviewed again. In these hospitals, the average proportion of unjustified hysterectomies had dropped from 23.7 per cent at the time of the first review to 7.8 per cent in 1974. The total number of hysterectomies in the province dropped by 32.8 per cent between 1970 and 1974.

Adolescent↗
PubMedDate not supplied

Management of NSAID-induced gastropathy: an economic decision analysis.

The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a 2% to 4% annual incidence of serious gastrointestinal complications. These adverse clinical outcomes, and the strategies used to prevent their occurrence, translate into a significant economic burden. A decision-analysis model was constructed to contrast the 6-month costs associated with various approaches to preventing and managing NSAID-induced gastropathy and to evaluate the economic impact of two treatment regimens using fixed-dose formulations of diclofenac/misoprostol. After incorporating expected medical out-comes and predicted practice patterns, 6-month per-patient costs were derived from the model for each of five treatment regimens: (1) NSAID alone; (2) NSAID with a histamine2-receptor antagonist; (3) NSAID with coprescribed misoprostol; (4) diclofenac/misoprostol 50 mg/200 micrograms TID/BID; and (5) diclofenac/misoprostol 75 mg/200 micrograms BID. The combined diclofenac/misoprostol regimens demonstrated an 18.6% per-patient cost advantage compared with the combined NSAID regimens. Based on a 6-month period, this cost savings translated into a $214.00 per-patient overall cost savings ($1153.00 per patient for NSAID regimens versus $939.00 for diclofenac/misoprostol regimens). The magnitude of this difference was verified by Monte Carlo simulation. Despite the considerable cost difference, sensitivity analyses revealed that our model was robust and that no single variation substantially influenced the results. Given the lack of long-term prospective, comparative clinical-outcomes studies in this area, this decision analysis provides guidance to clinicians in developing a rational and cost-effective approach to the treatment of patients requiring chronic NSAID therapy.

Anti-Inflammatory Agents, Non-Steroidal↗